Plasmacytoma — Trials

Plasmacytoma — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02544308	Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma(IDRIS)	active not recruiting	Phase 3	36	University College, LondonOTHER	1	Dec 23, 2022	clinicaltrials
NCT02336386	CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma	unknown	Phase 3	100	Beijing Chao Yang HospitalOTHER	1	Jan 13, 2015	clinicaltrials